Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOTOX and JUVÉDERM for Jawline and Neck Appearance
NCT07794891Phase 4Recruiting
- Sponsor
- AbbVie Inc.
- Start
- Sep 2026
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
A Phase 4 trial of botulinum toxin type A in 19p13.3 microduplication syndrome, platysma prominence, sponsored by AbbVie Inc.. Started Sep 2026; status: recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
19p13.3 microduplication syndromeplatysma prominence
Beyond the preview
Go deeper on NCT07794891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07794891.